News
12h
TipRanks on MSNBristol-Myers Squibb’s Promising Study on Luspatercept for α-Thalassemia
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
12h
TipRanks on MSNBristol-Myers Squibb’s New Alzheimer’s Study: Potential Market Impact
Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
Malcolm Ethridge from Capital Area Planning Group sees potential in ServiceNow, Inc. despite recent dip. Bristol-Myers and ...
The Cleveland Clinic's Nathan Pennell, M.D., Ph.D., is switching to the Big Pharma realm to head up hematology and oncology ...
12h
Zacks.com on MSNBMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?
Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.
U.S. pharma bounced back in Q2, and in this episode of "The Top Line," Fierce Pharma's Eric Sagonowsky and Kevin Dunleavy ...
Bristol-Myers Squibb has been navigating some choppy waters but seems poised for a turnaround. Recently, shares have ticked ...
NEW YORK – Krystal Biotech has discontinued a Phase I/II clinical trial evaluating an injected version of its gene therapy KB707 in locally advanced or metastatic solid tumors, including melanoma.
Southwind Foods, a California-based company, "voluntarily" recalled a select amount of frozen shrimp due to possible ...
The FDA advises consumers not to eat the recalled products. Traces of Cesium-137 are widespread in the environment including ...
First-time disclosures session at ACS Fall 2025 reveals diverse candidates for treating sickle cell disease, heart failure, ...
The FDA has updated its recall for frozen shrimp to include new grocery stores and states. Americans are being urged to check their freezers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results